ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 173 filers reported holding ANI PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,299 | -30.3% | 39,602 | -35.4% | 0.00% | -20.0% |
| Q2 2023 | $3,300 | -99.9% | 61,302 | -30.8% | 0.01% | +66.7% |
| Q1 2022 | $2,491,000 | -45.1% | 88,602 | -10.1% | 0.00% | -50.0% |
| Q4 2021 | $4,539,000 | +137.3% | 98,502 | +69.0% | 0.01% | +200.0% |
| Q3 2021 | $1,913,000 | -19.0% | 58,300 | -13.5% | 0.00% | -33.3% |
| Q2 2021 | $2,362,000 | -43.3% | 67,379 | -41.5% | 0.00% | -40.0% |
| Q1 2021 | $4,163,000 | -8.5% | 115,202 | -26.5% | 0.01% | 0.0% |
| Q4 2020 | $4,551,000 | +12.8% | 156,704 | +9.6% | 0.01% | +25.0% |
| Q3 2020 | $4,034,000 | -28.1% | 143,002 | -17.5% | 0.00% | -20.0% |
| Q2 2020 | $5,608,000 | -47.5% | 173,400 | -33.9% | 0.01% | -50.0% |
| Q1 2020 | $10,686,000 | -34.8% | 262,300 | -1.4% | 0.01% | -23.1% |
| Q4 2019 | $16,398,000 | -32.5% | 265,900 | -20.2% | 0.01% | -38.1% |
| Q3 2019 | $24,284,000 | +2.5% | 333,200 | +15.7% | 0.02% | 0.0% |
| Q2 2019 | $23,682,000 | +68.5% | 288,100 | +44.6% | 0.02% | +61.5% |
| Q1 2019 | $14,052,000 | +84.3% | 199,200 | +17.6% | 0.01% | +62.5% |
| Q4 2018 | $7,626,000 | -24.4% | 169,400 | -5.0% | 0.01% | -20.0% |
| Q3 2018 | $10,087,000 | -53.7% | 178,400 | -48.9% | 0.01% | -16.7% |
| Q2 2018 | $21,805,000 | +113.2% | 349,000 | +98.6% | 0.01% | +9.1% |
| Q1 2018 | $10,229,000 | -32.0% | 175,700 | -24.7% | 0.01% | -35.3% |
| Q4 2017 | $15,036,000 | -1.3% | 233,300 | -19.6% | 0.02% | -5.6% |
| Q3 2017 | $15,238,000 | +9.5% | 290,300 | -2.4% | 0.02% | 0.0% |
| Q2 2017 | $13,918,000 | +1.1% | 297,400 | +7.0% | 0.02% | -5.3% |
| Q1 2017 | $13,764,000 | -2.4% | 278,000 | +19.5% | 0.02% | -13.6% |
| Q4 2016 | $14,106,000 | +11.4% | 232,700 | +21.9% | 0.02% | 0.0% |
| Q3 2016 | $12,666,000 | +207.1% | 190,900 | +158.3% | 0.02% | +175.0% |
| Q2 2016 | $4,125,000 | +20.5% | 73,900 | +35.1% | 0.01% | +14.3% |
| Q1 2015 | $3,422,000 | -8.1% | 54,702 | -17.1% | 0.01% | -22.2% |
| Q4 2014 | $3,722,000 | +363.5% | 66,002 | +132.4% | 0.01% | +350.0% |
| Q3 2014 | $803,000 | -80.2% | 28,402 | -75.9% | 0.00% | -77.8% |
| Q2 2014 | $4,054,000 | – | 117,702 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 348,106 | $13,826,771 | 5.10% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 206,328 | $8,195 | 2.80% |
| Global Alpha Capital Management Ltd. | 462,961 | $18,388,811 | 1.67% |
| Worth Venture Partners, LLC | 85,558 | $3,398,364 | 1.66% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $273,750 | 1.14% |
| Parkman Healthcare Partners LLC | 100,000 | $3,972,000 | 0.86% |
| MARATHON CAPITAL MANAGEMENT | 84,890 | $3,371,831 | 0.83% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 306,277 | $12,165,322 | 0.72% |
| EMERALD ADVISERS, LLC | 373,406 | $14,831,686 | 0.71% |
| Rubric Capital Management LP | 648,041 | $25,740,189 | 0.67% |